Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
A perspective case series study
In order to qualify, adults must have heart disease and either overweight or obesity
North Texas GME Research Forum 2024 Files Download Poster or Presentation (224 KB) Division North Texas Hospital Medical City Weatherford Specialty Internal Medicine Document Type Poster Publication Date 2024 Keywords bariatric surgery, glucagon-like peptide (GLP-1) receptor agonists Disciplines Internal Medicine | Medicine and Health Sciences | Surgical Procedures, Operative Abstract Glucagon-like peptide receptor agonists (GLP-1 RA) are FDA-approved medications for the treatment of type 2 diabetes mellitus, and obesity, and are also beneficial in cardiovascular risk reduction
Perhaps most notably for many patients, GLP-1 receptor agonists act on appetite centers in the brain, promoting satiety and reducing food intake
Retatrutide is one of the most talked-about next-generation compounds in metabolic research
If a platform you're evaluating can't support each of these checks, that's the signal to pause before you pay
US$ 21.98
US$ 25.87
US$ 29.82
US$ 23.95
US$ 23.31
![In an earlier analysis of the SURMOUNT-1 trial, tirzepatide (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3585945231426876830)
